Chapter 316: Billion-dollar market! Blueprint for the future!
"This product will solve the problem that has plagued the industry for more than 30 years, and will also push artificial blood vessels into the 6-millimeter era..."
On the stage, Xu Qiu's voice was steady and calm, revealing a sophistication and calmness that was inconsistent with his age.
Old tool people like Wang Shengde and Academician Chen have long been accustomed to this.
Leaders such as Fu Qing were amazed.
He is not the kind of nerd who only knows how to do scientific research?
Daxia has picked up a treasure!
...
"After my discussion with the researchers of the Linhai University Research Institute, the new artificial blood vessel will be named "Linhai", and its full name is Linhai Small Caliber Artificial Blood Vessel..."
Soon, Xu Qiu revealed the first answer.
Yang Chenxi, Ren Chao and others sighed slightly.
How could this be discussed with us?
At the meeting, the entire institute hoped to name it "Xu's Small Caliber Artificial Blood Vessel".
The researchers involved in the research knew very well that without Xu Qiu, they might not be able to produce this product in ten or twenty years.
There was no hope at all!
Xu Qiu had already built the framework of the new blood vessel. All the researchers had to do was to conduct experiments and research according to Xu Qiu's plan...
Where else can you find a boss who gives you a plan, tells you how to do the experiment, and pays you extremely generously, except Xu Qiu?
To put it bluntly.
Except for Yang Chenxi who brought the equipment to the site, all the others were replaced. If they went to major research institutes to recruit a group of corresponding researchers, this thing could be made.
But if Xu Qiu was replaced, no one could succeed.
However, Xu Qiu did not seem to be interested in these false names, but left the naming rights to Linhai City.
In the auditorium, the mayor of Linhai City, Fu Qing, were all surprised.
They did not expect that it would be this name in the end.
This is equivalent to letting the world know that there is a city called Linhai in Baiyun Province of Daxia!
In Daxia, Tiandu, Modu, Yangcheng, and Pengcheng are the four major international cities.
Other provinces and cities do not have a strong sense of existence.
Linhai City may be able to take this opportunity to improve its international reputation, and the benefits it brings are absolutely immeasurable.
And the upper level Baiyun Province will only gain greater benefits.
…
"The second one is the price."
"Considering the R\u0026D funds and the payback period, etc..."
"The initial domestic price is the same as the previous 8mm caliber artificial blood vessels, with an average price of 30,000 yuan.
The overseas selling price is between 60,000 and 120,000 yuan."
As soon as these words came out, the auditorium suddenly became lively.
Everyone was extremely excited.
30,000 yuan!
Originally, they thought that the domestic selling price of small-caliber blood vessels would at least double, at least 60,000 yuan.
But Xu Qiu set the price at 30,000.
This is the price before entering the medical insurance...After the medical insurance intervenes, it will only be lower.
Everyone present is smart, and naturally understands what this price means.
With an investment of 600 million yuan and a market of 10 billion yuan, if the average price is 60,000 yuan, this product can quickly pay back the cost through global monopoly and start to make a profit.
But Xu Qiu cut the price in half and set it at 30,000.
Although this price can still make a lot of money with the huge market, this is actually Xu Qiushi's way of benefiting the people.
The 60,000 to 120,000 yuan sold abroad should be the normal price!
"This is the real domestic product, not making a penny more from the people..."
"30,000, I never expected it to be 30,000. Even if it is 60,000 or 90,000, this blood vessel is a blessing for those who have lost hope of treatment!"
"More than 600,000 patients who need vascular reconstruction every year are waiting indefinitely. Linhai's small-caliber artificial blood vessels are their only hope. As a result, it only costs 30,000 yuan in China! If there is a chance to include it in medical insurance, it will be even lower!"
At this time, the director of the Health Commission and the director of the Drug Administration of Daxia were also surprised.
30,000 is a discount for Daxia's own people.
The 60,000 to 120,000 yuan sold abroad leaves a buffer range for subsequent negotiations.
For example, Daxia needs to reduce the price of 8mm Macovi's blood vessels from 30,000 yuan to 10,000 yuan. In exchange, Daxia will also give Macovi a certain discount for this small-caliber blood vessel.
Xu Qiu's move was watertight...
Isn't he a seasoned manipulator who plays with the market and hangs around the negotiation table?
...
"The third one."
"Later, Linhai First Hospital will conduct the second, third and fourth small-caliber artificial blood vessel replacement surgeries.
Our hospital will also open clinical application qualification applications to the whole country.
At present, the first batch of hospitals allowed to conduct clinical surgical experiments simultaneously with Linhai First Hospital have been determined:
Tiandu Fuwai Hospital.
Tiandu Union Hospital.
Sichuan West China Hospital.
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology."
Off the field, many hospital directors were very excited.
They didn't expect that Xu Qiu didn't intend to monopolize this technology, but was willing to share it with the whole country!
Everyone knew the first four hospitals approved to conduct clinical trials.
The president of Union Hospital has been very close to Linhai First Hospital recently, and it is estimated that some py deal has been reached long ago.
Let's not talk about Fuwai, Yang Chenxi, Ma Qin, and a bunch of equipment are all from there.
As for West China and Tongji.
The former is because it has made great achievements in the field of vascular transplantation, and it can be regarded as recruiting high-level peers to participate in the experiment to make up for the defect that Linhai First Hospital, except for Xu Qiu and Director Zheng, has no high-level small-caliber transplant doctors for the time being.
The latter, Tongji has a close relationship with Academician Chen, and Academician Chen has a close relationship with Xu Qiu.
The liver cancer robot resection surgery was specially approved by Academician Chen to Linhai First Hospital.
The two companies have a mutually beneficial relationship and belong to a distant firm alliance.
Many deans are eager to try.
Mastering this operation and obtaining small-caliber blood vessels supplied by Linhai Research Institute, their hospital can overtake in this field!
One step faster, every step faster, this truth is understood by everyone.
Therefore, they all made up their minds that after the meeting, they must have a good talk with Xu Qiu, cardiac surgery and the top management of Linhai First Hospital. No matter what the cost, they must get this quota!
……
……
The meeting lasted more than two hours in the end.
The future of Linhai's small-caliber artificial blood vessels has also been basically defined in Xu Qiu's plain narration.
In addition to the several key points announced by Xu Qiu.
The leaders of the Health Commission, the first secretary of Baiyun Province, and the mayor of Linhai City have all issued special instructions, proposing to establish an industrial base for this independently developed product to supply the huge market demand in the future.
The medical industry is different from others.
Once the six-millimeter blood vessel is made, even if its performance is not good, it is destined to become the only choice for all small-caliber blood vessel transplant patients, and there will inevitably be a huge market demand.
What's more, Xu Qiu's product is of excellent quality, and the early animal experiments and current human clinical operations have performed very well.
Therefore, the city, the province, and even the country are willing to invest heavily.
According to the preliminary plan, the first phase of the artificial blood vessel production plant will reach 15,000 square meters, which is expected to be completed at the end of this year. It will be gradually expanded and increased in production capacity in the future, and the annual output will eventually be guaranteed to be more than 100,000 sets.
Of course, the investment cost is also extremely staggering.
The reason why the province dared to invest so much money is that, in addition to the huge demand for the Linhai small-caliber artificial blood vessels after their launch, there is another more important factor.
